https://www.prnewswire.com/news-releases/lillys-donanemab-receives-us-fdas-breakthrough-therapy-designation-for-treatment-of-alzheimers-disease-301318931.html
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.76 |
Change
0.000(0.00%) |
Mkt cap ! $298.8M | |||
| Open | High | Low | Value | Volume |
| $1.77 | $1.77 | $1.76 | $47.62K | 26.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1096 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 1657 | 1 |
View Market Depth
| Last trade - 10.19am 18/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |